Hidehito Horinouchi: AT-EVDNA Identified as Key Driver of Anti-Cancer Immune Activation
Hidehito Horinouchi/X

Hidehito Horinouchi: AT-EVDNA Identified as Key Driver of Anti-Cancer Immune Activation

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:

“Activated T cell extracellular vesicle transfer DNA (AT-EVDNA)

Activated T cells secrete abundant AT-EVDNA

AT-EVDNA enhances antigen presentation & anti-tumor immunity

Dr. Mengying Hu.”

Title: Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity

Authors: Mengying Hu, Di-Ao Liu, Inbal Wortzel, Paul Collier, Theodore M. Nelson, Jonathan Foox, Guojie Zhong, Gabriel Tobias, Tetsuhiko Asao, Linda Bojmar, Candia M. Kenific, Gang Wang, Simone Caielli, Zurong Wan, Sarah Qureshy, Max Reed, Richard Piszczatowski, Purnima Ravisankar, Julia A. Brown, Sihan Xiong, Huajuan Wang, Pernille Lauritzen, Yael Aylon, Henrik Molina, William R. Jarnagin, Moshe Oren, Ben Z. Stanger, Jack Bui, Gabriele Bergers, Agnès Noël, Paul M. Grandgenett, Michael A. Hollingsworth, David Tuveson, Nancy Boudreau, Jacqueline Bromberg, David Kelsen, David R. Jones, Laura Santambrogio, Melody Y. Zeng, Virginia Pascual, Han Sang Kim, Christopher E. Mason, Haiying Zhang, Irina R. Matei, David Lyden

Read the Full Article.

Hidehito Horinouchi: AT-EVDNA Identified as Key Driver of Anti-Cancer Immune Activation

Other articles featuring Hidehito Horinouchi.